ENSC (Ensysce Biosciences) Cash Payments


ENSC Ensysce Biosciences Inc ENSC
23 GF Score
Price $0.28
! 2 Warning Signs
View Full Analysis

What is Ensysce Biosciences Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

ENSC
23GF Score
Ensysce Biosciences Inc ENSC
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ensysce Biosciences Business Description

Address 7946 Ivanhoe Avenue, Suite 201, La Jolla, CA, USA, 92037
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
23GF Score

Get the complete analysis for ENSC

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price